help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on August 16, 2007
Endocrinology, doi:10.1210/en.2007-0325
A more recent version of this article appeared on November 1, 2007
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
148/11/5582    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ribaux, P.
Right arrow Articles by Halban, P. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ribaux, P.
Right arrow Articles by Halban, P. A.

Submitted on March 9, 2007
Accepted on August 7, 2007

Induction of CXCL1 by extracellular matrix and autocrine enhancement by IL-1 in rat pancreatic {beta}-cells

Pascale Ribaux*, Jan A. Ehses, Nathalie Lin-Marq, Fabio Carrozzino, Marianne Böni-Schnetzler, Eva Hammar, Jean-Claude Irminger, Marc Donath, and Philippe A. Halban

Department of Genetic Medicine and Development, University Medical Center, Geneva, Switzerland, Division of Endocrinology and Diabetes, University Hospital of Zürich, Switzerland, Department of Cellular Physiology and Metabolism, University Medical Center, Geneva, Switzerland

* To whom correspondence should be addressed. E-mail: Pascale.Ribaux{at}medecine.unige.ch.

As we showed previously, the extracellular matrix (ECM) derived from rat bladder carcinoma cells (804G-ECM) has positive effects on rat primary {beta}-cell function and survival in vitro. The aim of this study was to define {beta}-cell genes induced by this ECM with a specific focus on cytokines. Analysis of differential gene expression by oligonucleotide microarrays, RT-PCR and in situ hybridization was performed to identify cytokine mRNA induced by this matrix. Four cytokines were overexpressed on 804G-ECM compared to poly-L-lysine: CXCL1, CXCL2, IP10 and IL-1{beta}. A time-course experiment indicated that maximal induction by 804G-ECM of CXCL1/2 and IP10 occurred at 4 hours. Stimulation of CXCL1 release by {beta}-cells on 804G-ECM was confirmed at the protein level. Moreover, secreted CXCL1 was shown to be functionally active by attracting rat granulocytes. Preventing the interaction of {beta}1 integrins and laminin-5 (a major component of 804G-ECM) with specific antibodies resulted in a 40–50% inhibition of CXCL1 expression. Using the NF-{kappa}B pathway inhibitor Bay 11–7082 it is demonstrated that CXCL1 expression and secretion are dependent on NF-{kappa}B activation. IL-1 secreted by {beta}-cells plated on 804G-ECM was found to be a key soluble mediator, since treatment of cells with the IL-1 receptor antagonist significantly reduced both CXCL1 gene expression and secretion. It is concluded that ECM induces expression of cytokines including CXCL1 with amplification by IL-1 acting via a positive autocrine feedback loop.


Key words: {beta}-cell • cytokine • extracellular matrix • gene expression




This article has been cited by other articles:


Home page
DiabetesHome page
K. Bouzakri, P. Ribaux, A. Tomas, G. Parnaud, K. Rickenbach, and P. A. Halban
Rab GTPase-Activating Protein AS160 Is a Major Downstream Effector of Protein Kinase B/Akt Signaling in Pancreatic {beta}-Cells
Diabetes, May 1, 2008; 57(5): 1195 - 1204.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2007 by The Endocrine Society